Condition: Stroke, Ischemic · Aphasia · Sponsor: Changping Laboratory
The objective of this trial is to evaluate the effectiveness and safeness of continuous Theta Burst Stimulation (cTBS) over the right Inferior Frontal Gyrus (IFG), guided by personalized Brain Functional Sector (pBFS) technology, on language function recovery in patients with post-ischemic stroke aphasia.
This description comes directly from the study's public registry record.
Jianting Huang, MD,PhD · 010-80726688 · jianting.huang@pku.edu.cn
Ruiqi Pan · 010-80726688 · ruiqipanedu@163.com
Always discuss trial participation with your own doctor first.
| First Affiliated Hospital of Fujian Medical University | Fuzhou, Fujian, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05907031